Metastases Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Metastases stocks.

Metastases Stocks Recent News

Date Stock Title
Nov 21 NVCR Novocure Data at 2024 SNO Annual Meeting Highlights Product Innovation and Real-World Evidence for Tumor Treating Fields (TTFields) Therapy in Glioblastoma
Nov 21 NVCR FDA Approves Novocure’s Innovative HFE Transducer Arrays for Use With Optune Gio® for Glioblastoma
Nov 20 AMGN AMGEN ANNOUNCES SENIOR EXECUTIVE RESEARCH APPOINTMENT
Nov 20 AMGN SLN Stock Down Despite Cholesterol Drug Lowering Lipoprotein Levels
Nov 19 AMGN Amgen Stock Has High Implied Volatility. An Iron Condor Takes Advantage.
Nov 19 AMGN Silence Therapeutics' Zerlasiran Has Competitive Concerns: Analyst
Nov 18 AMGN Amgen Sells Off: Keep Calm And Buy The Dip
Nov 18 AMGN Is Amgen Inc. (AMGN) the Best Immunotherapy Stock to Buy Now?
Nov 18 AMGN Dow Tumbles Over 300 Points Following Economic Reports, Nvidia, Microsoft Decline: Fear & Greed Index Moves To 'Neutral' Zone
Nov 16 AMGN The weight-loss frenzy is making some pharma stocks much more volatile. Will the drama continue?
Nov 16 AMGN 2 Reasons to Buy Amgen Stock, and 1 Reason to Be Cautious
Nov 16 AMGN The three-year decline in earnings for Amgen NASDAQ:AMGN) isn't encouraging, but shareholders are still up 50% over that period
Nov 15 AMGN Large pharmas, biotechs down as industries grapple with RFK Jr. at HHS
Nov 14 AMGN AMGEN PRESENTS NEW DATA ACROSS RARE INFLAMMATORY DISEASES AT ACR 2024
Nov 14 CADL Candel Therapeutics reports Q3 results
Nov 14 AMGN Amgen Shrugs Off Bone Density Concerns Related to Obesity Candidate
Nov 14 AMGN 5 Healthcare Stocks to Buy in a Beaten-Up Sector
Nov 14 VCYT High Growth Tech Stocks To Watch In November 2024
Metastases

Metastasis is a pathogenic agent's spread from an initial or primary site to a different or secondary site within the host's body; the term is typically used when referring to metastasis by a cancerous tumor. The newly pathological sites, then, are metastases (mets). It is generally distinguished from cancer invasion, which is the direct extension and penetration by cancer cells into neighboring tissues.Cancer occurs after cells are genetically altered to proliferate rapidly and indefinitely. This uncontrolled proliferation by mitosis produces a primary heterogeneic tumour. The cells which constitute the tumor eventually undergo metaplasia, followed by dysplasia then anaplasia, resulting in a malignant phenotype. This malignancy allows for invasion into the circulation, followed by invasion to a second site for tumorigenesis.
Some cancer cells known as circulating tumor cells acquire the ability to penetrate the walls of lymphatic or blood vessels, after which they are able to circulate through the bloodstream to other sites and tissues in the body. This process is known (respectively) as lymphatic or hematogenous spread. After the tumor cells come to rest at another site, they re-penetrate the vessel or walls and continue to multiply, eventually forming another clinically detectable tumor. This new tumor is known as a metastatic (or secondary) tumor. Metastasis is one of the hallmarks of cancer, distinguishing it from benign tumors. Most cancers can metastasize, although in varying degrees. Basal cell carcinoma for example rarely metastasizes.When tumor cells metastasize, the new tumor is called a secondary or metastatic tumor, and its cells are similar to those in the original or primary tumor. This means that if breast cancer metastasizes to the lungs, the secondary tumor is made up of abnormal breast cells, not of abnormal lung cells. The tumor in the lung is then called metastatic breast cancer, not lung cancer. Metastasis is a key element in cancer staging systems such as the TNM staging system, where it represents the "M". In overall stage grouping, metastasis places a cancer in Stage IV. The possibilities of curative treatment are greatly reduced, or often entirely removed when a cancer has metastasized.

Browse All Tags